Together, these findings highlight ITGA2’s central role within the tumor microenvironment and multifactorial signaling network: not only is it finely regulated upstream, but it also extensively engages with key pathways such as PD-L1 and TGF-β, potentially collectively mediating drug resistance. This evidence concerns the gene CD274 and neoplasm.